Download Docs
Export

ABRAXIS ONCOLOGY

78865042 | Trademark

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed April 19, 2006
Serial No. 78865042
Registered Dec. 22, 2009
Registration No. 3,730,110
Interlocutory Attorney ELIZABETH WINTER
Class pharmaceuticals for the treatment of cancer; pharmaceuticals, namely, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; nanoparticles for drug delivery or imaging agent delivery sold as an integral component of drugs or imaging agents; 006; 018; 044; 046; 051; 052
ABRAXIS ONCOLOGY
Status Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Opposition 91199307
Celgene Corporation v. Ablexis, LLC
  • Ablexis, LLC;
  • Celgene Corporation;
Last Updated: 5 months ago
Filing Date # Docket Text